We delve into ICER’s influence on drug pricing and access in the US. We also explore the importance of maximising engagement with ICER for favourable pricing and access outcomes.
Read More
We're thrilled to announce that Mtech Access will be exhibiting at the ISPOR conference May 5–8 in Atlanta, Georgia, USA! As regular attendees of ISPOR Europe, we're excited to be...
Read More
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...
Read More
We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.
Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the...
Read More
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice...
Read More
In this webinar, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or...
Read More
How can a digital approach enhance local customer communication, particularly when tools are adapted from existing global materials?
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
